Ex-Novo Nordisk protégé Schultz becomes Lundbeck CEO

After a dramatic exit from Novo Nordisk last week, its former COO Kåre Schultz has been named CEO of Lundbeck.

After a dramatic exit from Novo Nordisk last week, its former COO Kåre Schultz has been named CEO of Lundbeck.

Mr Schultz spent 26 years at Novo and was slated to take on the job of CEO at the company...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Neurological

More from Therapeutic Category